Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)

NCT07193953 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
ALS

Interventions

DEVICE: Next Generation Dome Helmet Focused Ultrasound
DRUG: Intravenous immunoglobulin (IVIG), 10% solution for infusion
DRUG: Definity® Vial for (Perflutren Lipid Microsphere) Injectable Suspension

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]